According to the World Health Organization (WHO), colic and functional constipation are among the three most common gastrointestinal disorders, affecting 20% and 15% of infants respectively. These disorders are hypothesised to incur a significant financial burden, trigger doctor consultations and hospital visits, and decrease the quality of life of infants and their families.
There is growing evidence that common gut disorders that present during infancy are accompanied by gut dysbiosis and are mediated by gut flora. The incidence of gastrointestinal intolerance is lower among infants who receive breastmilk, however, many mothers cease breastfeeding early and introduce formula into their infants’ diets, often without consulting a health professional.
While FGID are generally thought to be benign and self-resolving, community pharmacists may need to focus on educating parents and caregivers on identifying signs and symptoms, as well as appropriate management of these disorders, while concurrently providing support and reassurance.
This activity has been accredited for 1.00 hour(s) of Group 2 CPD (or 2.00 CPD Credit(s)) suitable for inclusion in an individual pharmacist’s CPD plan
BPharm MClinPharm PhD MPS
Professor of Pharmacy (Head of Discipline)
Director International Engagement and Recruitment,
School of Clinical Sciences
Queensland University of Technology
MBBS BSc(Med) MMed FRACP PhD
Gastroenterologist, Campbelltown Hospital, Sydney
Senior Lecturer, School of Medicine,
Western Sydney University
On completion of this program, participants will be better able to:
- Identify signs and symptoms of infantile colic and constipation, and distinguish from other gastrointestinal disorders
- Provide practical advice on the management of infantile colic and constipation
- Recognise when referral is required
- Review infant nutrition treatment options including infant formulas and provide guidance and tailored advice on infant nutrition